These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
358 related items for PubMed ID: 1705001
41. Effect of dexamethasone on the antileukemic effect of cytarabine: role of deoxycytidine kinase. Jaramillo AC, Bergman AM, Comijn EM, Jansen G, Kaspers GJL, Cloos J, Peters GJ. Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1346. PubMed ID: 32727269 [Abstract] [Full Text] [Related]
42. In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine in human leukemia cells. Grant S, Boise L, Westin E, Howe C, Pettit GR, Turner A, McCrady C. Biochem Pharmacol; 1991 Jul 25; 42(4):853-67. PubMed ID: 1867641 [Abstract] [Full Text] [Related]
43. Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene. Beauséjour CM, Gagnon J, Primeau M, Momparler RL. Biochem Biophys Res Commun; 2002 May 24; 293(5):1478-84. PubMed ID: 12054682 [Abstract] [Full Text] [Related]
44. The effect of 5-azacytidine (5-aza-CR) and its analogue on cell differentiation and DNA methylation of HL-60 cells. He ZX, Rao H. Sci China B; 1993 Apr 24; 36(4):430-8. PubMed ID: 7691071 [Abstract] [Full Text] [Related]
45. Comparison of antineoplastic activity of cytosine arabinoside and 5-aza-2'-deoxycytidine against human leukemic cells of different phenotype. Momparler RL, Onetto-Pothier N, Momparler LF. Leuk Res; 1990 Apr 24; 14(9):755-60. PubMed ID: 1700231 [Abstract] [Full Text] [Related]
46. Cellular metabolism of 5,6-dihydro-5-azacytidine and its incorporation into DNA and RNA of human lymphoid cells CEM/O and CEM/dCk(-). Avramis VI, Powell WC, Mecum RA. Cancer Chemother Pharmacol; 1989 Apr 24; 24(3):155-60. PubMed ID: 2472227 [Abstract] [Full Text] [Related]
47. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells. Grant S, Bhalla K, McCrady C. Leuk Res; 1991 Apr 24; 15(4):205-13. PubMed ID: 2030601 [Abstract] [Full Text] [Related]
48. In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) gene. Stegmann AP, Honders MW, Hagemeijer A, Hoebee B, Willemze R, Landegent JE. Ann Hematol; 1995 Jul 24; 71(1):41-7. PubMed ID: 7543292 [Abstract] [Full Text] [Related]
49. Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside. Flasshove M, Strumberg D, Ayscue L, Mitchell BS, Tirier C, Heit W, Seeber S, Schütte J. Leukemia; 1994 May 24; 8(5):780-5. PubMed ID: 7514246 [Abstract] [Full Text] [Related]
50. Interaction of deoxycytidine and deoxycytidine analogs in normal and leukemic human myeloid progenitor cells. Grant S, Bhalla K, Gleyzer M. Leuk Res; 1986 May 24; 10(9):1139-46. PubMed ID: 2429121 [Abstract] [Full Text] [Related]
51. Transfection of wild-type deoxycytidine kinase (dck) cDNA into an AraC- and DAC-resistant rat leukemic cell line of clonal origin fully restores drug sensitivity. Stegmann AP, Honders WH, Willemze R, Ruiz van Haperen VW, Landegent JE. Blood; 1995 Mar 01; 85(5):1188-94. PubMed ID: 7532033 [Abstract] [Full Text] [Related]
52. Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells. Bhalla K, Cole J, MacLaughlin W, Arlin Z, Baker M, Graham G, Grant S. Leukemia; 1987 Dec 01; 1(12):814-9. PubMed ID: 2447450 [Abstract] [Full Text] [Related]
53. Epigenetic action of decitabine (5-aza-2'-deoxycytidine) is more effective against acute myeloid leukemia than cytotoxic action of cytarabine (ARA-C). Momparler RL, Côté S, Momparler LF. Leuk Res; 2013 Aug 01; 37(8):980-4. PubMed ID: 23660386 [Abstract] [Full Text] [Related]
54. Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosine. Ross DD, Cuddy DP, Cohen N, Hensley DR. Cancer Chemother Pharmacol; 1992 Aug 01; 31(1):61-70. PubMed ID: 1458561 [Abstract] [Full Text] [Related]
55. Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study. Raza A, Gezer S, Anderson J, Lykins J, Bennett J, Browman G, Goldberg J, Larson R, Vogler R, Preisler HD. Exp Hematol; 1992 Nov 01; 20(10):1194-200. PubMed ID: 1426099 [Abstract] [Full Text] [Related]
56. Differential effect of GM-CSF pretreatment on intracellular Ara-C metabolism in normal bone marrow mononuclear cells vs acute myeloid leukemia (AML) blasts. Reuter C, Schleyer E, Rolf C, Wörmann B, Büchner T, Hiddemann W. Leukemia; 1997 Apr 01; 11(4):561-71. PubMed ID: 9096697 [Abstract] [Full Text] [Related]
57. Dose- and schedule-dependent activation and drug synergism between thymidine and 5-aza-2'-deoxycytidine in a human promyelocytic leukemia cell line. Grant S, Rauscher F, Margolin J, Cadman E. Cancer Res; 1982 Feb 01; 42(2):519-24. PubMed ID: 6173114 [Abstract] [Full Text] [Related]
58. Immunocytochemical detection of deoxycytidine kinase in pediatric malignancies in relation to in vitro cytarabine sensitivity. Hubeek I, Peters GJ, Broekhuizen AJ, Talianidis I, Schouten van Meeteren AY, van Wering ER, Gibson B, Creutzig U, Kaspers GJ. Nucleosides Nucleotides Nucleic Acids; 2004 Oct 01; 23(8-9):1351-6. PubMed ID: 15571257 [Abstract] [Full Text] [Related]
59. Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells. Song JH, Kim SH, Kweon SH, Lee TH, Kim HJ, Kim HJ, Kim TS. Int J Oncol; 2009 Apr 01; 34(4):1165-71. PubMed ID: 19287976 [Abstract] [Full Text] [Related]
60. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells. Momparler RL, Veselý J, Momparler LF, Rivard GE. Cancer Res; 1979 Oct 01; 39(10):3822-7. PubMed ID: 476619 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]